TY - JOUR
T1 - Distribution of norovirus and sapovirus genotypes with emergence of NoV GII.P16/GII.2 recombinant strains in Chiang Mai, Thailand
AU - Supadej, Kanittapon
AU - Khamrin, Pattara
AU - Kumthip, Kattareeya
AU - Malasao, Rungnapa
AU - Chaimongkol, Natthawan
AU - Saito, Mayuko
AU - Oshitani, Hitoshi
AU - Ushijima, Hiroshi
AU - Maneekarn, Niwat
N1 - Funding Information:
We gratefully acknowledge financial support from the CMU 50th Anniversary Ph.D. program (grant no. PHD/025/2556), and the Center of Excellence (Emerging and Re‐emerging Diarrheal Viruses Research Center) (grant no. ST6392 (11)/1089), Chiang Mai University, Chiang Mai, Thailand.
Funding Information:
We gratefully acknowledge financial support from the CMU 50th Anniversary Ph.D. program (grant no. PHD/025/2556), and the Center of Excellence (Emerging and Re-emerging Diarrheal Viruses Research Center) (grant no.?ST6392 (11)/1089), Chiang Mai University, Chiang Mai, Thailand.
Publisher Copyright:
© 2018 Wiley Periodicals, Inc.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Norovirus (NoV) and sapovirus (SaV) are recognized as the causative agents of acute gastroenteritis, and NoV is one of the leading pathogens reported worldwide. This study reports on the distribution of NoV and SaV genotypes in children hospitalized with acute gastroenteritis in Chiang Mai, Thailand, from January 2015 to February 2017. From a total of 843 stool samples, 170 (20.2%) and 16 (1.9%) were identified as having NoV and SaV infections, respectively. Two samples (0.2%) were positive for both NoV and SaV. Of these, NoV GII.4 (57.2%) was the dominant genotype, followed by GII.2, GII.3, GII.17, GII.6, GII.7, GII.13, GII.14, GII.15, GII.21, GI.6, and GI.5. Among the NoV GII.4 variants, Sydney 2012 was the dominant variant during the period 2015-2016, while the other variants detected in this study were Asia 2003 and New Orleans 2009. Interestingly, an increase of NoV GII.2 was observed in 2016 and 2017. Characterization of partial RNA-dependent RNA polymerase and VP1 nucleotide sequences of GII.2 strains revealed that more than half of the GII.2 strains circulating in 2016 and 2017 were recombinant strains of GII.P16/GII.2. For SaV, the majority of strains belonged to GI.1 (55.6%) and GI.2 (33.3%), while GII.5 accounted for 11.1%. In conclusion, this study demonstrates the diversity of NoV and SaV, and the emergence of NoV GII.P16/GII.2 recombinant strains in 2016 and 2017 in Chiang Mai, Thailand.
AB - Norovirus (NoV) and sapovirus (SaV) are recognized as the causative agents of acute gastroenteritis, and NoV is one of the leading pathogens reported worldwide. This study reports on the distribution of NoV and SaV genotypes in children hospitalized with acute gastroenteritis in Chiang Mai, Thailand, from January 2015 to February 2017. From a total of 843 stool samples, 170 (20.2%) and 16 (1.9%) were identified as having NoV and SaV infections, respectively. Two samples (0.2%) were positive for both NoV and SaV. Of these, NoV GII.4 (57.2%) was the dominant genotype, followed by GII.2, GII.3, GII.17, GII.6, GII.7, GII.13, GII.14, GII.15, GII.21, GI.6, and GI.5. Among the NoV GII.4 variants, Sydney 2012 was the dominant variant during the period 2015-2016, while the other variants detected in this study were Asia 2003 and New Orleans 2009. Interestingly, an increase of NoV GII.2 was observed in 2016 and 2017. Characterization of partial RNA-dependent RNA polymerase and VP1 nucleotide sequences of GII.2 strains revealed that more than half of the GII.2 strains circulating in 2016 and 2017 were recombinant strains of GII.P16/GII.2. For SaV, the majority of strains belonged to GI.1 (55.6%) and GI.2 (33.3%), while GII.5 accounted for 11.1%. In conclusion, this study demonstrates the diversity of NoV and SaV, and the emergence of NoV GII.P16/GII.2 recombinant strains in 2016 and 2017 in Chiang Mai, Thailand.
KW - Thailand
KW - diarrhea
KW - norovirus
KW - recombination
KW - sapovirus
UR - http://www.scopus.com/inward/record.url?scp=85055154361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055154361&partnerID=8YFLogxK
U2 - 10.1002/jmv.25261
DO - 10.1002/jmv.25261
M3 - Article
C2 - 29995327
AN - SCOPUS:85055154361
VL - 91
SP - 215
EP - 224
JO - Journal of Medical Virology
JF - Journal of Medical Virology
SN - 0146-6615
IS - 2
ER -